Literature DB >> 18360822

Reversible optic neuropathy with OPA1 exon 5b mutation.

Karen Cornille1, Dan Milea, Patrizia Amati-Bonneau, Vincent Procaccio, Lydie Zazoun, Virginie Guillet, Ghizlane El Achouri, Cécile Delettre, Naïg Gueguen, Dominique Loiseau, Agnès Muller, Marc Ferré, Arnaud Chevrollier, Douglas C Wallace, Dominique Bonneau, Christian Hamel, Pascal Reynier, Guy Lenaers.   

Abstract

A new c.740G>A (R247H) mutation in OPA1 alternate spliced exon 5b was found in a patient presenting with bilateral optic neuropathy followed by partial, spontaneous visual recovery. R247H fibroblasts from the patient and his unaffected father presented unusual highly tubular mitochondrial network, significant increased susceptibility to apoptosis, oxidative phosphorylation uncoupling, and altered OPA1 protein profile, supporting the pathogenicity of this mutation. These results suggest that the clinical spectrum of the OPA1-associated optic neuropathies may be larger than previously described, and that spontaneous recovery may occur in cases harboring an exon 5b mutation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18360822     DOI: 10.1002/ana.21376

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  13 in total

1.  OPA1 links human mitochondrial genome maintenance to mtDNA replication and distribution.

Authors:  Ghizlane Elachouri; Sara Vidoni; Claudia Zanna; Alexandre Pattyn; Hassan Boukhaddaoui; Karen Gaget; Patrick Yu-Wai-Man; Giuseppe Gasparre; Emmanuelle Sarzi; Cécile Delettre; Aurélien Olichon; Dominique Loiseau; Pascal Reynier; Patrick F Chinnery; Agnès Rotig; Valerio Carelli; Christian P Hamel; Michela Rugolo; Guy Lenaers
Journal:  Genome Res       Date:  2010-10-25       Impact factor: 9.043

Review 2.  Dominant optic atrophy.

Authors:  Guy Lenaers; Christian Hamel; Cécile Delettre; Patrizia Amati-Bonneau; Vincent Procaccio; Dominique Bonneau; Pascal Reynier; Dan Milea
Journal:  Orphanet J Rare Dis       Date:  2012-07-09       Impact factor: 4.123

3.  [Hereditary optic atrophies].

Authors:  C M Poloschek; W A Lagrèze
Journal:  Ophthalmologe       Date:  2009-09       Impact factor: 1.059

Review 4.  Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.

Authors:  Patrick Yu-Wai-Man; Philip G Griffiths; Patrick F Chinnery
Journal:  Prog Retin Eye Res       Date:  2010-11-26       Impact factor: 21.198

5.  Pathogenicity evaluation and the genotype-phenotype analysis of OPA1 variants.

Authors:  Xingyu Xu; Panfeng Wang; Xiaoyun Jia; Wenmin Sun; Shiqiang Li; Xueshan Xiao; J Fielding Hejtmancik; Qingjiong Zhang
Journal:  Mol Genet Genomics       Date:  2021-04-21       Impact factor: 3.291

6.  Multi-system neurological disease is common in patients with OPA1 mutations.

Authors:  P Yu-Wai-Man; P G Griffiths; G S Gorman; C M Lourenco; A F Wright; M Auer-Grumbach; A Toscano; O Musumeci; M L Valentino; L Caporali; C Lamperti; C M Tallaksen; P Duffey; J Miller; R G Whittaker; M R Baker; M J Jackson; M P Clarke; B Dhillon; B Czermin; J D Stewart; G Hudson; P Reynier; D Bonneau; W Marques; G Lenaers; R McFarland; R W Taylor; D M Turnbull; M Votruba; M Zeviani; V Carelli; L A Bindoff; R Horvath; P Amati-Bonneau; P F Chinnery
Journal:  Brain       Date:  2010-02-15       Impact factor: 13.501

Review 7.  Treatment of hereditary optic neuropathies.

Authors:  Nancy J Newman
Journal:  Nat Rev Neurol       Date:  2012-09-04       Impact factor: 42.937

8.  Genetic screening for OPA1 and OPA3 mutations in patients with suspected inherited optic neuropathies.

Authors:  Patrick Yu-Wai-Man; Suma P Shankar; Valérie Biousse; Neil R Miller; Lora J H Bean; Bradford Coffee; Madhuri Hegde; Nancy J Newman
Journal:  Ophthalmology       Date:  2010-10-30       Impact factor: 12.079

Review 9.  The optic nerve: a "mito-window" on mitochondrial neurodegeneration.

Authors:  Alessandra Maresca; Chiara la Morgia; Leonardo Caporali; Maria Lucia Valentino; Valerio Carelli
Journal:  Mol Cell Neurosci       Date:  2012-08-15       Impact factor: 4.314

10.  Acute and late-onset optic atrophy due to a novel OPA1 mutation leading to a mitochondrial coupling defect.

Authors:  Yannick Nochez; Sophie Arsene; Naig Gueguen; Arnaud Chevrollier; Marc Ferré; Virginie Guillet; Valérie Desquiret; Annick Toutain; Dominique Bonneau; Vincent Procaccio; Patrizia Amati-Bonneau; Pierre-Jean Pisella; Pascal Reynier
Journal:  Mol Vis       Date:  2009-03-27       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.